Pulmonary zygomycosis in a patient treated for invasive aspergillosis;Zygomycose pulmonaire chez un patient traité pour une aspergillose invasive possible

Medecine et Maladies Infectieuses

Volumn 36, Issue 2, 2006, Pages 118-121

  Tricot, S ^a   Gastine, T ^a   Sendid, B ^a   Wurtz, A ^a   De Botton, S ^a   Alfandari, S ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Service de Reanimation et Maladies Infectieuses   (France)

Author keywords

Antifungal agents; Aspergillosis; Zygomycoses

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; VORICONAZOLE;

ABSIDIA; ADULT; ARTICLE; ASPERGILLOSIS; CASE REPORT; FOLLOW UP; HUMAN; LUNG MYCOSIS; MUCORMYCOSIS;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; DRUG THERAPY, COMBINATION; HUMANS; ITRACONAZOLE; LEUKEMIA; MALE; RADIOGRAPHY, THORACIC; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; ZYGOMYCOSIS;

EID: 33644502548     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.12.003     Document Type: Article

References (10)

1. S. Ascioglu, J.H. Rex, and B. De Pauw Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin. Infect. Dis. 34 2002 7 14
2. R.M. Prabhu, and R. Patel Mucomycosis and entemophtoramycosis: a review of the clinical manifestations, diagnosis and treatment Eur. J. Clin. Microbiol. Infect. Dis. 10 S1 2004 31 47
3. e version, novembre 2004 Med. Mal. Infect. 35 2005 121 134
4. E. Dannaoui, J. Meletiadis, J.W. Mouton, J.F. Meis, P.E. Verweij Eurofung Network In vitro susceptibilities of zygomycetes to conventional and new antifungials J. Antimicrob. Chemother. 51 2003 45 52
5. J. Singh, D. Rimek, and R. Kappe In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method Mycoses 48 2005 246 250
6. K.A. Marr, R.A. Carter, F. Crippa, A. Wald, and L. Corey Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin. Infect. Dis. 34 2002 909 917
7. G.T. Siwek, K.J. Dodgson, M. De Magalhaes-Silverman, L.A. Bartelt, S.B. Kilborn, and P.L. Hoth Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis Clin. Infect. Dis. 39 2004 584 587
8. A. Imhof, S.A. Balajee, D.N. Fredericks, J.A. Englund, and K.A. Marr Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole Clin. Infect. Dis. 39 2004 743 746
9. S. Vigouroux, O. Morin, P. Moreau, F. M̀chinaud, N. Morineau, and B. Mah́ Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required Clin. Infect. Dis. 40 2005 e35 e37
10. D.P. Kontoyiannis, M.S. Lionakis, R.E. Lewis, G. Chamilos, M. Healy, and C. Perego Zygomycosis in a tertiary care cancer center in the era of aspergillus active antifugal therapy: a case control observational study of 27 recent cases J. Infect. Dis. 191 2005 1350 1360